Insulina lispro
RxNorm 86009· ATC A10AB04· insulin lispro
KR · 한국Productos en Corea (23)
- 휴마로그믹스25카트리지주100단위/mL(별첨)한국릴리(유)
- 휴마로그믹스25카트리지주100단위/mL한국릴리(유)
- 휴마로그믹스25카트리지주100단위/mL한국릴리(유)
- 휴마로그믹스25퀵펜주100단위/밀리리터(유전자재조합인슐린라이스프로25%와인슐린라이스프로프로타민현탁액75%혼합액)한국릴리(유)
- 휴마로그믹스25퀵펜주100단위/밀리리터(유전자재조합인슐린라이스프로25%와인슐린라이스프로프로타민현탁액75%혼합액)한국릴리(유)
- 휴마로그믹스25퀵펜주100단위/밀리리터(유전자재조합인슐린라이스프로25%와인슐린라이스프로프로타민현탁액75%혼합액)한국릴리(유)
- 휴마로그믹스25퀵펜주100단위/밀리리터(유전자재조합인슐린라이스프로25%와인슐린라이스프로프로타민현탁액75%혼합액)한국릴리(유)
- 휴마로그주100단위/밀리리터(인슐린라이스프로)한국릴리(유)
- 휴마로그퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 휴마로그퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 휴마로그퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 휴마로그퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 휴마로그믹스 50 카트리지주 100단위/밀리리터(인슐린라이스프로 50%와 인슐린라이스프로 프로타민현탁액 50% 혼합액)한국릴리(유)
- 휴마로그믹스 50 카트리지주 100단위/밀리리터(인슐린라이스프로 50%와 인슐린라이스프로 프로타민현탁액 50% 혼합액)한국릴리(유)
- 휴마로그믹스 50 카트리지주 100단위/밀리리터(인슐린라이스프로 50%와 인슐린라이스프로 프로타민현탁액 50% 혼합액)한국릴리(유)
- 휴마로그믹스50퀵펜주100단위/밀리리터(인슐린라이스프로50%와인슐린라이스프로프로타민현탁액50%혼합액)한국릴리(유)
- 휴마로그믹스50퀵펜주100단위/밀리리터(인슐린라이스프로50%와인슐린라이스프로프로타민현탁액50%혼합액)한국릴리(유)
- 휴마로그믹스50퀵펜주100단위/밀리리터(인슐린라이스프로50%와인슐린라이스프로프로타민현탁액50%혼합액)한국릴리(유)
- 휴마로그믹스50퀵펜주100단위/밀리리터(인슐린라이스프로50%와인슐린라이스프로프로타민현탁액50%혼합액)한국릴리(유)
- 휴마로그에이치디퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 휴마로그에이치디퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 룸제브퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
- 룸제브퀵펜주100단위/밀리리터(인슐린라이스프로유전자재조합)한국릴리(유)
U.S. drug label (openFDA)
Humalog — indications, dosage, warnings, adverse events →Química (PubChem)
- Fórmula molecular
- C257H389N65O77S6
- Peso molecular
- 5814 g/mol
- Nombre IUPAC
- (4S)-4-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2R)-2-[[(2R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[(2-aminoacetyl)amino]-3-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]-5-[[(2S)-4-amino-1-[[(2S)-1-[[(2R)-1-[[(1S)-3-amino-1-carboxy-3-oxopropyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-5-oxopentanoic acid;(4S)-4-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-methylbutanoyl]amino]-4-oxobutanoyl]amino]-5-oxopentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-4-carboxybutanoyl]amino]propanoyl]amino]-4-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-3-methylbutanoyl]amino]-3-sulfanylpropanoyl]amino]acetyl]amino]-5-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[(2S)-2-[[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl]pyrrolidin-1-yl]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-oxopentanoic acid
- InChIKey
- WNRQPCUGRUFHED-DETKDSODSA-N